Back to search

Article

Novel genomic risk loci and improved prediction for treatment-resistant schizophrenia are revealed by leveraging polygenic overlap with body-mass index

2022-10-31

Abstract excerpt

<title>Abstract</title> <p>Treatment resistant schizophrenia (TRS) is characterized by repeated treatment failure with antipsychotics. A recent genome-wide association study (GWAS) of TRS showed a polygenic architecture, but no significant loci were identified. Clozapine is shown to be the superior drug in terms of clinical effect in TRS; at the same time it has a serious side effect profile, including weight gai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
92a0a715-015d-536d-8e49-70a0666632e0
DOI
10.21203/rs.3.rs-2198111/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel genomic risk loci and improved prediction for treatment-resistant schizophrenia are revealed by leveraging polygenic overlap with body-mass indexDOI 10.21203/rs.3.rs-2198111/v1
Select a neighboring publication to make it the new centre.